# MDoloris Medical Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdoloris-medical-systems

- Industry: Medical Devices & Equipment
- Headquarters: Loos, France
- Website: www.mdoloris.com
- Total disclosed funding: $8.1M
- Latest round: Series C (Nov 8, 2018)
- Investors on record: 5

## About

MDoloris Medical Systems SAS develops innovative non-invasive technologies for monitoring and managing pain in patients. Their solutions enhance patient outcomes during surgical procedures and critical care, offering real-time insights into autonomic nervous system activity.MDoloris Medical Systems SAS, founded in 2010 and headquartered in Loos, France, specializes in non-invasive pain management solutions. The company has successfully raised EUR 6.5 million in its Series C funding round led by Seventure Partners, with participation from XAnge, as of November 2018. CEO Fabien Pagniez leads the firm, which has undergone significant development since its inception, having completed 7 total funding deals to date, with a current valuation of EUR 17.876 mn.MDoloris Medical Systems specializes in non-invasive technologies designed to monitor and manage pain and nociception in patients undergoing surgical procedures or suffering from critical diseases. Their product lineup includes the ANI Monitor V2, ANI Monitor V1, NIPE Monitor V1, and PTA Monitor, which provide real-time insights into patients' autonomic nervous system responses. These devices are utilized in various settings such as operating rooms, intensive care units, pediatric intensive care units, and veterinary applications, serving a diverse clientele across Europe, North America, and select regions in Asia.In the most recent year, MDoloris Medical Systems reported revenue of EUR 4,003,560.60 and an EBITDA of EUR -1,779,235.80 for the year 2020. The company generates its revenue primarily through direct sales and partnerships with healthcare institutions and veterinary clinics that utilize its monitoring technologies.MDoloris Medical Systems plans to leverage its latest funding round to expand its product offerings and enter new markets. The company aims to introduce new monitoring devices and software solutions tailored for emerging healthcare trends. Additionally, MDoloris intends to penetrate new geographic markets in Asia and North America by 2024. The recent funding of EUR 6.5 million will be allocated to research and development, facilitating the rollout of these initiatives.

## Funding rounds

- Series C, Nov 8, 2018, $7.4M — Seventure Partners, XAnge
- Series A, Feb 3, 2014, $0.8M — Siparex Proximité Innovation, Finorpa, Finovam Gestion

## Investors

- Siparex Proximité Innovation (https://capitalatlas.ai/funds/siparex-proximite-innovation) — Series A
- Finorpa (https://capitalatlas.ai/funds/finorpa) — Series A
- Finovam Gestion (https://capitalatlas.ai/funds/finovam-gestion) — Series A
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series C
- XAnge (https://capitalatlas.ai/funds/xange) — Series C